Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10212062 | 0.94 | CA12 (0.46) | CA12CA1CA2CA7CA14 | |
| SCHEMBL497722 | 0.88 | — | — | |
| SCHEMBL12555548 | 0.88 | — | — | |
| SCHEMBL14113755 | 0.84 | CYP3A4 (0.44) | CA12CA1CA2CA7CA14 | |
| SCHEMBL26230598 | 0.84 | — | — | |
| SCHEMBL13568618 | 0.84 | CYP3A4 (0.44) | CA12CA1CA2CA7CA14 | |
| SCHEMBL17484366 | 0.84 | — | — | |
| SCHEMBL17526839 | 0.84 | CYP3A4 (0.44) | CA12CA1CA2CA7CA14 | |
| SCHEMBL26230599 | 0.84 | — | — | |
| SCHEMBL813042 | 0.82 | CYP3A4 (0.47) | CA1CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113929797-A | Solid catalyst component and catalyst system for producing polymers | 中国石油化工股份有限公司 | 2022-01-14 | — | — | CN | claimed |
| CN-113773424-A | Catalyst component for olefin polymerization and application | 中国石油化工股份有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-100478369-C | Olefin and omega-silane-alpha-olefin copolymer and its preparing method | CHINESE ACAD INST CHEMISTRY (CN) | 2009-04-15 | — | — | CN | claimed |
| CN-1935858-A | Olefin and omega-silane-alpha-olefin copolymer and its preparing method | CHINESE ACAD INST CHEMISTRY (CN) | 2007-03-28 | — | — | CN | claimed |
| US-20230287418-A1 | MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY | TUOJIE BIOTECH(SHANGHAI) CO., LTD. (CN) | 2023-09-14 | — | — | US | disclosed |
| CN-113929797-A | Solid catalyst component and catalyst system for producing polymers | 中国石油化工股份有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-113773424-A | Catalyst component for olefin polymerization and application | 中国石油化工股份有限公司 | 2021-12-10 | — | — | CN | disclosed |
| CN-112300304-A | Catalyst system for olefin polymerization and prepolymerized catalyst composition | 中国石油化工股份有限公司 | 2021-02-02 | — | — | CN | disclosed |
| EP-3578562-A1 | L-VALINATE AMIDE BENZOXABOROLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES | Anacor Pharmaceuticals, Inc (US) | 2019-12-11 | — | — | EP | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-20140135329-A1 | Pyridine and Pyrazine derivative for the Treatment of CF | BAETTIG URS (GB) | 2014-05-15 | — | — | US | disclosed |
| US-8623621-B2 | Method for producing optically active 2-methyl-alkanols | BASF SE (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20110045560-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-METHYL-ALKANOLS | BASF AKTIENGESELLSCHAFT (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7816107-B2 | Method for producing an optically active 2-methyl-alkane-1-ol from the corresponding 2-methylalk-2-en-1-al, comprising carbonyl-selective reduction, enantioselective hydration and lipase-catalyzed, stereoselective acylation in order to enrich the desired | BASF AKTIENGESELLSCHAFT (DE) | 2010-10-19 | — | — | US | disclosed |
| US-7736620-B2 | Europium-diketone chelate compound and fluorescent material using the same | NATIONAL UNIVERSITY CORPORATION KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2010-06-15 | — | — | US | disclosed |
| CN-100478369-C | Olefin and omega-silane-alpha-olefin copolymer and its preparing method | CHINESE ACAD INST CHEMISTRY (CN) | 2009-04-15 | — | — | CN | disclosed |
| US-20080108117-A1 | Method for Producing an Optically Active 2-Methyl-Alkane-1-Ol from the Corresponding 2-Methylalk-2-En-1-Al, Comprising Carbonyl-Selective Reduction, Enantioselective Hydration and Lipase-Catalyzed Stereoselective Acylation in Order to Enrich the Desired | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | disclosed |
| EP-1797191-B1 | PROESS FOR PRODUCING AN OPTICALLY ACTIVE 2-METHYL-ALKANE-1-OLS FROM THE CORRESPONDING 2-METHYLALK-2-EN-1-ALS, COMPRISING A STEP OF ENANTIOSELECTIVE ACYLATION TO ENRICH ONE ENANTIOMER | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| CN-1935858-A | Olefin and omega-silane-alpha-olefin copolymer and its preparing method | CHINESE ACAD INST CHEMISTRY (CN) | 2007-03-28 | — | — | CN | disclosed |
| US-4971937-A | COORDINATION CATALYSTS OF TITANIUM HALIDES, MAGNESIUM HALIDES AND DI OR POLYETHER COMPOUNDS | HIMONT INCORPORATED (US) | 1990-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135329-A1 | Pyridine and Pyrazine derivative for the Treatment of CF | CFTR, OPRK1, OPRD1 | CA12 4266/4885CA1 4833/4885CA2 3279/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | CA12 2348/4885CA1 3481/4885CA2 4828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.